Delivery Order SPE2DB22D1017-SPE2DB24FF0HR

Award Date 12/26/23
Potential Completion Date 12/27/23
Potential Value $4.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,131.69, is a Firm Fixed Price Delivery Order that runs through November 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,829.96, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a firm fixed price and an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,138.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2023. The contract has an ultimate completion date of December 13, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $5,133.55, was awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Multaq 400 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a total ceiling value of $2,777.16 and an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,358.67 and is a firm-fixed-price delivery order, with a period of performance ending on February 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,065.40 Firm Fixed Price Delivery Order covers the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract has a ceiling value of $5,149.77 and is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract does not have a set-aside designation and is set to expire on June 17, 2024. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for the delivery of 4566374215 MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $20,357.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $8,687.77 and a period of performance through January 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF0HR
    Delivery Order

This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $4,830.43 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/13/25, 10:14 AM